The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

In a late-stage clinical trial, Wegovy (semaglutide) significantly reduced liver inflammation and reversed scarring in people with the liver disease MASH. MASH is associated with obesity and type ...

A study in weight loss drugs where one third of participants were given a placebo turned out to have some impressive results.

The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions in body weight and waist circumference.

The company is preparing a Phase 3 trial of enobosarm with a novel formulation that could extend its patent life.

Many folks in NC can’t access Ozempic due to limited insurance coverage. But policy changes and falling prices may expand ...

Doctors are also seeing success in treating people with certain liver diseases. Isaacs prescribes GLP-1s for people with a ...

Researchers found GLP-1s may modestly reduce the risk of 14 obesity-related cancers, especially colorectal cancer, when ...